论文部分内容阅读
目的:观察与探究合并原发性消化道癌的胃间质瘤临床病理。方法:选取2014年03月~2017年03月期间于本院就诊及治疗的100例胃间质瘤患者作为研究对象,合并原发性消化道癌的胃间质瘤患者有15例,分析15例合并原发性消化道癌的胃间质瘤患者的临床病理。结果:100例胃间质瘤患者中,合并存在原发性消化道癌的胃间质瘤的患者占15.00%;其中,胃小间质瘤有10例,微小胃间质瘤有5例。合并原发性消化道癌的胃间质瘤患者的核分裂象都小于5/50高倍视野;CD117的阳性率为93.33%,CD34的阳性率为93.33%,DOG-1的阳性率为93.33%;按照Fletcher分级,低危有33.33%、极低危有66.67%。结论:合并原发性消化道癌的胃间质瘤患者不存在特异性的临床特征,临床病理方面也没有特异性的免疫组织化学的标志。
Objective: To observe and explore the clinicopathological features of gastric stromal tumors with primary gastrointestinal cancer. METHODS: A total of 100 patients with gastric stromal tumors treated and treated in our hospital from March 2014 to March 2017 were selected as the study subjects. Fifteen patients with gastric stromal tumors with primary gastrointestinal cancer were analyzed and 15 Case of primary gastrointestinal stromal tumors in patients with gastrointestinal cancer clinicopathology. Results: Among the 100 patients with gastric stromal tumors, 15.00% were associated with gastric cancer with primary gastrointestinal cancer. Of these, 10 were gastric small stromal tumors and 5 were micro-gastric stromal tumors. The mitotic figures of patients with gastric cancer with primary gastrointestinal cancer were less than 5/50 high power field. The positive rate of CD117 was 93.33%, the positive rate of CD34 was 93.33%, the positive rate of DOG-1 was 93.33% According to the Fletcher classification, there is a low risk of 33.33% and a very low risk of 66.67%. Conclusions: There are no specific clinical features in patients with gastric stromal tumor with primary gastrointestinal cancer, and there is no specific immunohistochemical sign in clinicopathology.